AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30511430 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antibiotic paste with minocycline (TAPm)
Number of subjects: 50
Study 28777242 — intervention group
Group type: EXPERIMENTAL
Intervention: NR1I2 rs3814055:C>T genotypes (CC, CT, TT)
Number of subjects: 240
Study 28777242 — intervention group
Group type: EXPERIMENTAL
Intervention: TAC dose administered to minor T allele carriers (CT or TT genotype)
Number of subjects: 240
Study 28777242 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP3A5 expressers excluded from analysis
Number of subjects: 240
Study 26033349 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile app and pedometer intervention
Number of subjects: 61
Study 26033349 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 61
Study 23977257 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifocal perinatal home-visiting intervention using psychologists
Number of subjects: 440
Study 23977257 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 440
Study 21744191 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pharmacy services, intensive follow-up by a clinical pharmacist for 6 months.
Number of subjects: 152
Study 21744191 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care provided to control group patients for 6 months.
Number of subjects: 152
Study 19337777 — intervention group
Group type: EXPERIMENTAL
Intervention: Water spray
Number of subjects: 120
Study 19337777 — intervention group
Group type: COMPARATOR
Intervention: Sitz bath
Number of subjects: 120
Study 16778714 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg after pretreatment with clarithromycin 800 mg/d
Number of subjects: 18
Study 16778714 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg after pretreatment with fluvoxamine 50 mg/d
Number of subjects: 18
Study 16778714 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg after pretreatment with placebo
Number of subjects: 18
Study 16778714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 15306269 — intervention group
Group type: EXPERIMENTAL
Intervention: Male condom
Number of subjects: 108
Study 15306269 — intervention group
Group type: COMPARATOR
Intervention: Female condom
Number of subjects: 108
Study 11781651 — intervention group
Group type: COMPARATOR
Intervention: IL‐10
Number of subjects: 0
Study 11781651 — intervention group
Group type: COMPARATOR
Intervention: TNF‐alpha
Number of subjects: 0
Study 11781651 — intervention group
Group type: EXPERIMENTAL
Intervention: IL‐6
Number of subjects: 0
Study 9668740 — intervention group
Group type: EXPERIMENTAL
Intervention: One-to-one midwifery (study group)
Number of subjects: 1403
Study 9668740 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 1403
Study 7817152 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.3 mg/kg body weight)
Number of subjects: 24
Study 7817152 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.3 mg/kg body weight) plus Ketamine (1.0 mg/kg body weight)
Number of subjects: 24
Study 7817152 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 24
Study 7817152 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam plus Ketamine
Number of subjects: 24
Study 7817152 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and Midazolam plus Ketamine
Number of subjects: 24
Study 3379143 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (0.5 mg intramuscularly or 1.0 mg orally)
Number of subjects: 34
Study 31323050 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Training (MT) - 4 sessions of 20 minutes each
Number of subjects: 66
Study 31323050 — intervention group
Group type: COMPARATOR
Intervention: Book Learning Control
Number of subjects: 66
Study 28569123 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanical embolectomy with the Trevo device
Number of subjects: 500
Study 28569123 — intervention group
Group type: COMPARATOR
Intervention: Standard medical therapy alone
Number of subjects: 500
Study 26554316 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated treatment in a specialized open hospital ward with disorder-specific group therapy
Number of subjects: 100
Study 26554316 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual in an open general psychiatric ward
Number of subjects: 100
Study 22983284 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycyrrhizin (75 mg three times daily for 6 days)
Number of subjects: 14
Study 22983284 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for 6 days)
Number of subjects: 14
Study 22983284 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycyrrhizin
Number of subjects: 14
Study 21733061 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin (50 mg qd)
Number of subjects: 515
Study 21733061 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 515
Study 19705923 — intervention group
Group type: EXPERIMENTAL
Intervention: tesofensine (0.3, 0.6, 0.9, 1.2 mg)
Number of subjects: 33
Study 19705923 — intervention group
Group type: EXPERIMENTAL
Intervention: meloxicam 30 mg
Number of subjects: 33
Study 19705923 — intervention group
Group type: COMPARATOR
Intervention: meloxicam 30 mg with cholestyramine
Number of subjects: 33
Study 16813885 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined orchiectomy and radiotherapy
Number of subjects: 91
Study 16813885 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone
Number of subjects: 91
Study 15052778 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 54
Study 15052778 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl
Number of subjects: 54
Study 12544371 — intervention group
Group type: EXPERIMENTAL
Intervention: Venlafaxine
Number of subjects: 68
Study 12544371 — intervention group
Group type: COMPARATOR
Intervention: Nortriptyline
Number of subjects: 68
Study 10884288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cultured skin fibroblasts from SLS patients
Number of subjects: 11
Study 10884288 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma concentrations in SLS patients
Number of subjects: 11
Study 10884288 — intervention group
Group type: COMPARATOR
Intervention: Cultured skin fibroblasts from normal controls
Number of subjects: 11
Study 8771595 — intervention group
Group type: EXPERIMENTAL
Intervention: triazolam (0.25 mg)
Number of subjects: 67
Study 8771595 — intervention group
Group type: COMPARATOR
Intervention: loprazolam (1 mg)
Number of subjects: 67
Study 1607582 — intervention group
Group type: EXPERIMENTAL
Intervention: Encainide, flecainide or moricizine (upwardly titrated doses)
Number of subjects: 2371
Study 1607582 — intervention group
Group type: EXPERIMENTAL
Intervention: Study drugs (encainide, flecainide or moricizine)
Number of subjects: 2371
Study 4042746 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcircumcision blood sampling at 30 min
Number of subjects: 80
Study 4042746 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcircumcision blood sampling at 90 min
Number of subjects: 80
Study 4042746 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcircumcision blood sampling at 120 min
Number of subjects: 80
Study 4042746 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcircumcision blood sampling at 240 min
Number of subjects: 80
Study 4042746 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional group of 10 newborns
Number of subjects: 80
Study 4042746 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral state observation during circumcision
Number of subjects: 80
Study 4042746 — intervention group
Group type: EXPERIMENTAL
Intervention: Quiet sleep observation
Number of subjects: 80
Study 4042746 — intervention group
Group type: EXPERIMENTAL
Intervention: Postcircumcision observation of quiet sleep
Number of subjects: 80
Study 3305114 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine 40 mg
Number of subjects: 11
Study 3305114 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg
Number of subjects: 11
Study 3305114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 30394918 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 38
Study 30394918 — intervention group
Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 38
Study 30394918 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil
Number of subjects: 38
Study 28452657 — intervention group
Group type: EXPERIMENTAL
Intervention: Ventriculosubgaleal shunts (VSGS)
Number of subjects: 145
Study 28452657 — intervention group
Group type: COMPARATOR
Intervention: Ventricular reservoirs (VR)
Number of subjects: 145
Study 28452657 — intervention group
Group type: EXPERIMENTAL
Intervention: VSGS
Number of subjects: 145
Study 28452657 — intervention group
Group type: COMPARATOR
Intervention: VR
Number of subjects: 145
Study 26182069 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-PPT SB
Number of subjects: 283
Study 26182069 — intervention group
Group type: EXPERIMENTAL
Intervention: General SB
Number of subjects: 283
Study 26182069 — intervention group
Group type: COMPARATOR
Intervention: Waiting List Control (WL)
Number of subjects: 283
Study 23837826 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise programme (30-min moderate-to-vigorous exercise)
Number of subjects: 56
Study 21641362 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin greater than the median (4,477 ng/mL)
Number of subjects: 3931
Study 19489234 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterolateral approach (< or = 10 cm incision)
Number of subjects: 110
Study 19489234 — intervention group
Group type: COMPARATOR
Intervention: Standard posterolateral approach
Number of subjects: 110
Study 16774900 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Lifestyle Program (MLP)
Number of subjects: 279
Study 16774900 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 279
Study 15377172 — intervention group
Group type: EXPERIMENTAL
Intervention: LJP 1082 (B-cell toleragen)
Number of subjects: 0
Study 11224578 — intervention group
Group type: EXPERIMENTAL
Intervention: High fluoride ingestion (2.4, 4.6, 5.6, and 13.5 mg/l)
Number of subjects: 200
Study 9143000 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticotropin-releasing hormone (CRH) 10 micrograms
Number of subjects: 10
Study 9143000 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenocorticotropic hormone (ACTH) 1 microgram
Number of subjects: 10
Study 9143000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 9143000 — intervention group
Group type: EXPERIMENTAL
Intervention: Corticotropin-releasing hormone (CRH)
Number of subjects: 10
Study 8204806 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparinase-modified TEG assay
Number of subjects: 51
Study 2976000 — intervention group
Group type: EXPERIMENTAL
Intervention: Acitretin-PUVA
Number of subjects: 65
Study 2976000 — intervention group
Group type: EXPERIMENTAL
Intervention: Etretinate-PUVA
Number of subjects: 65
Study 2976000 — intervention group
Group type: COMPARATOR
Intervention: Placebo-PUVA
Number of subjects: 65
Study 30664514 — intervention group
Group type: EXPERIMENTAL
Intervention: Mid-thoracic spine mobilization
Number of subjects: 33
Study 30664514 — intervention group
Group type: COMPARATOR
Intervention: Therapeutic exercise (foam roller exercises)
Number of subjects: 33
Study 29183529 — intervention group
Group type: EXPERIMENTAL
Intervention: One-step procedure of laparoscopic cholecystectomy (LC) with endoscopic retrograde cholangiopancreatography (ERCP) + endoscopic sphincterotomy (EST)
Number of subjects: 63
Study 29183529 — intervention group
Group type: COMPARATOR
Intervention: Two-step procedure of laparoscopic cholecystectomy (LC) with ERCP + EST
Number of subjects: 63
Study 25416723 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipilimumab (10 mg/kg in 11/15 patients)
Number of subjects: 15
Study 25416723 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose glucocorticoids (n=11) or physiological replacement doses (n=4)
Number of subjects: 15
Study 23311604 — intervention group
Group type: EXPERIMENTAL
Intervention: Coca-Cola without resin infiltration
Number of subjects: 30
Study 23311604 — intervention group
Group type: EXPERIMENTAL
Intervention: Coca-Cola with resin infiltration
Number of subjects: 30
Study 23311604 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprite without resin infiltration
Number of subjects: 30
Study 23311604 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprite with resin infiltration
Number of subjects: 30
Study 21597235 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary waiting at home on full pay if the family became Influenza like Illness (ILI) (Cohort 1)
Number of subjects: 15314
Study 21597235 — intervention group
Group type: COMPARATOR
Intervention: Not waiting at home (Cohort 2)
Number of subjects: 15314
Study 21597235 — intervention group
Group type: EXPERIMENTAL
Intervention: Workers asked to wait at home (Cohort 1)
Number of subjects: 15314
Study 21597235 — intervention group
Group type: COMPARATOR
Intervention: Workers whose family got ILI but were not asked to wait (Cohort 2)
Number of subjects: 15314
Study 18467909 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (30-60 ml/day)
Number of subjects: 190
Study 18467909 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (1 capsule three times/day containing Streptococcus faecalis 60 million, Clostridium butyricum 4 million, Bacillus mesentricus 2 million, lactic acid bacillus 100 million)
Number of subjects: 190
Study 18467909 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose plus probiotics
Number of subjects: 190
Study 16856904 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole plus amoxicillin (M+A) for 7 days
Number of subjects: 22
Study 16856904 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) and two placebos
Number of subjects: 22
Study 14531210 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan (Tracleer‐Actelion)
Number of subjects: 0
Study 11753266 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP3A4 induction (rifampin)
Number of subjects: 6
Study 11753266 — intervention group
Group type: EXPERIMENTAL
Intervention: CYP3A4 inhibition (troleandomycin)
Number of subjects: 6
Study 11753266 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 6
Study 8981374 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading visually presented words aloud (maximizes perceptual encoding)
Number of subjects: 0
Study 8981374 — intervention group
Group type: EXPERIMENTAL
Intervention: Generating words aloud from definitions (maximizes conceptual encoding)
Number of subjects: 0
Study 8981374 — intervention group
Group type: COMPARATOR
Intervention: Alzheimer's disease patients
Number of subjects: 0
Study 8493007 — intervention group
Group type: EXPERIMENTAL
Intervention: Peribulbar anesthesia
Number of subjects: 317
Study 8493007 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar anesthesia
Number of subjects: 317
Study 8493007 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 317
Study 3552198 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcomputerized Diagnostic Interview Schedule (DIS)
Number of subjects: 41
Study 3552198 — intervention group
Group type: COMPARATOR
Intervention: Standard problem-oriented non-structured clinical interview (NSI)
Number of subjects: 41
Study 31485774 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher expression levels of four genes (α‐pinene synthase, GPPS, MC5)
Number of subjects: 16
Study 31485774 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrations of two terpenoid compounds (β‐caryophyllene, α‐humulene)
Number of subjects: 16
Study 29562041 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management model with individual training on hypertension causes, risk factors, significance, unwanted side effects, medication treatment, and lifestyle changes.
Number of subjects: 0
Study 29562041 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention offered).
Number of subjects: 0
Study 26105535 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 57
Study 26105535 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Fitness Exercise Program
Number of subjects: 57
Study 26105535 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 57
Study 24044709 — intervention group
Group type: EXPERIMENTAL
Intervention: 810-nm subthreshold diode micropulse (SDM) laser treatment
Number of subjects: 15
Study 24044709 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 15
Study 21087166 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol (50-μg) plus oxytocin
Number of subjects: 101
Study 21087166 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin alone
Number of subjects: 101
Study 19293667 — intervention group
Group type: EXPERIMENTAL
Intervention: On-pump surgery
Number of subjects: 92
Study 19293667 — intervention group
Group type: COMPARATOR
Intervention: Off-pump surgery
Number of subjects: 92
Study 17108825 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 5 mg/kg
Number of subjects: 40
Study 17108825 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 14728932 — intervention group
Group type: EXPERIMENTAL
Intervention: Different chemotherapy regimens
Number of subjects: 9683
Study 14728932 — intervention group
Group type: EXPERIMENTAL
Intervention: EORTC QLQ-C30
Number of subjects: 9683
Study 11514368 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary gamma-irradiation (15 Gy at 2 mm from the source)
Number of subjects: 89
Study 11514368 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose gamma-irradiation (18 Gy at 2 mm from the source)
Number of subjects: 89
Study 11514368 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Long WRIST)
Number of subjects: 89
Study 9024023 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg IV administered at the end of surgery
Number of subjects: 0
Study 9024023 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg IV administered before induction of anesthesia
Number of subjects: 0
Study 9024023 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline 5 mL) administered prior to induction and at the end of surgery
Number of subjects: 0
Study 8440855 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention strategy including moderate intensity endurance-building exercise (walking), strength and balance training, home safety improvements, and mental practice
Number of subjects: 1323
Study 8440855 — intervention group
Group type: COMPARATOR
Intervention: Usual care from the HMO
Number of subjects: 1323
Study 3325331 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 X 2.5 mg dihydroergotamine (DETMS retard) daily (n = 10)
Number of subjects: 30
Study 3325331 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets (n = 10)
Number of subjects: 30
Study 29544871 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter PFO closure
Number of subjects: 120
Study 29544871 — intervention group
Group type: COMPARATOR
Intervention: Medication-only group (Control)
Number of subjects: 120
Study 26452718 — intervention group
Group type: EXPERIMENTAL
Intervention: Resource facilitation services for 15 months
Number of subjects: 44
Study 26452718 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 25376140 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthrocentesis (AC) with corticosteroids (dexamethasone 8 mg)
Number of subjects: 60
Study 25376140 — intervention group
Group type: COMPARATOR
Intervention: Arthrocentesis (AC) without corticosteroids
Number of subjects: 60
Study 25376140 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (AC with and without corticosteroids)
Number of subjects: 60
Study 22579678 — intervention group
Group type: EXPERIMENTAL
Intervention: CAB sequence
Number of subjects: 340
Study 22579678 — intervention group
Group type: COMPARATOR
Intervention: ABC sequence
Number of subjects: 340
Study 20122374 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoteleconferencing anger management therapy (n = 61)
Number of subjects: 125
Study 20122374 — intervention group
Group type: COMPARATOR
Intervention: In-person anger management therapy (n = 64)
Number of subjects: 125
Study 17976228 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 mug/kg IV over 10 min)
Number of subjects: 14
Study 17976228 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 14
Study 16049200 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 40 mg
Number of subjects: 391
Study 16049200 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391
Study 16049200 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin and Placebo
Number of subjects: 391
Study 12109024 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen-fragmented words presented individually to observers
Number of subjects: 40
Study 10079448 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative glare sensitivity in pseudophakic group
Number of subjects: 25
Study 10079448 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative visual acuity and contrast sensitivity correlation
Number of subjects: 25
Study 10079448 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative visual acuity and glare difference correlation
Number of subjects: 25
Study 10079448 — intervention group
Group type: COMPARATOR
Intervention: Age and visual acuity correlation in control group
Number of subjects: 25
Study 10079448 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeatability of Y-VA examinations
Number of subjects: 25
Study 7559887 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH plus atenolol (1 mg/kg)
Number of subjects: 11
Study 7559887 — intervention group
Group type: COMPARATOR
Intervention: GHRH plus placebo
Number of subjects: 11
Study 1617922 — intervention group
Group type: EXPERIMENTAL
Intervention: roxithromycin 300 mg once daily
Number of subjects: 1588
Study 1617922 — intervention group
Group type: COMPARATOR
Intervention: roxithromycin 150 mg b.i.d.
Number of subjects: 1588
Study 6089857 — intervention group
Group type: EXPERIMENTAL
Intervention: edrophonium 1 mg kg‐1
Number of subjects: 23
Study 6089857 — intervention group
Group type: COMPARATOR
Intervention: neostigmine 35.7 micrograms kg‐1
Number of subjects: 23
Study 29952699 — intervention group
Group type: EXPERIMENTAL
Intervention: FAST-FR (high-velocity foam rolling)
Number of subjects: 17